摘要
目的:研究"胃肠安"方对胃癌术后患者生存率和肿瘤转移的作用。方法:采用前瞻性随机分组,将95例进展期胃癌根治术后患者分为中药组、中西医结合组和西药组进行治疗,观察3组患者的生存率及转移率。结果:中西医结合组的3年、5年生存率为75.9%、62.8%,高于西药组的52.8%、26.4%,差异有统计学意义(P<0.05)。中药组、中西医结合组的5年转移率分别为27.78%、29.41%,明显低于西药组的56%,差异有统计学意义(P<0.05)。中西医结合组和中药组的5年累计转移率没有显著性差异(P>0.05)。结论:含"胃肠安"方的中西医结合治疗能显著提高胃癌术后患者的生存率;"胃肠安"方能显著降低胃癌术后转移率。
Objective： To observe the effect of Wei Chang An recipe on the survival and metastasis rate of the gastric cancer patients during post-operative period, nethods：A prospective randomized, controlled study was conducted by dividing the 95 patients with advanced gastric cancer into three groups： TCM group, western medicine group, and combined therapy group. The survival and the metastasis rate of the patients were observed. Results： The 3-and 5-year survival rate was 75, 9% and 62.8% in the combined therapy group, respectively. They were significantly higher than those in the western medicine group （52.8% and 26.4%, P 〈0.05 ）. The 5- year metastasis rate was 27.78% and 29.41% in the TCM group and the combined therapy group, which were significantly lower than that in the Western medicine group （56 %, P 〈0.05 ）. The 5-year metastasis i＇ate had no significant difference between the TCM group and combined therapy group （ P 〉 0.05 ）. Conclusion ： The Wei Chang An recipe combined with western medicine significantly increased the survival rate of gastric cancer patients during post-operative period. Wei Chang An recipe remarkably decreases the postoperative metastasis rate.
出处
《肿瘤》
CAS
CSCD
北大核心
2007年第6期487-489,共3页
Tumor
关键词
胃肿瘤/中西医结合疗法
治疗结果
肿瘤转移
Stomach neoplasms/Zhong si yi jie he liao fa
Treatment outcome
Neoplasms metastasis
作者简介
周浩（1969-），男（汉族），硕士，主治医师 Correspondence to：ZHOU Hao（周浩）Tel：021-58835753-130 E-mail：haoz2000@gmail.com
